Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection.
about
A Rationally Designed TNF-α Epitope-Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen-Induced Arthritis in MiceTargeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis.Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammationImmunization against an IL-6 peptide induces anti-IL-6 antibodies and modulates the Delayed-Type Hypersensitivity reaction in cynomolgus monkeys.Vaccination with cytokines in autoimmune diseases.Emerging applications of anticytokine vaccines.IL-1 Vaccination Is Suitable for Treating Inflammatory Diseases.Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis.Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis.An IL-17 peptide-based and virus-like particle vaccine enhances the bioactivity of IL-17 in vitro and in vivo.Targeting TGF-beta1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis.Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers.
P2860
Q28554288-F9ECA5FC-E633-44C1-8C41-29CB6A054565Q34452035-B654A2E4-7D4E-47C1-A14A-B60C31AF998FQ35136750-BCC8A6D6-F41F-4D27-9162-ADD5765EAF60Q35540023-EF3A1F27-8BBC-439D-9FE7-DA98AB17CB2AQ36499879-D55DE6F2-752A-460D-BA81-C492070886ABQ37165366-091B4F6F-A89D-448D-A64C-D7E8C7369EEDQ37340457-931B00F0-D9DB-4616-B8E8-3608C446246DQ37614491-90C186DC-BB17-4584-AAAE-5684E6AFBAFCQ37773295-B93B9113-19BB-4111-A617-50DA6DBD6BC4Q37850806-685B2BD2-E81A-49FE-9ED4-6C54042D550DQ40485583-83B72F12-9573-402E-B87B-353BA4F58877Q42827899-E73D7E35-FD7D-45F4-B22C-0295A566B0A6Q43238854-482F0D21-2253-4510-A074-AE88990A66B5Q45069341-937C91FB-5B56-4484-96BD-379AD384786A
P2860
Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Active immunization against mu ...... tokine and in vivo protection.
@en
type
label
Active immunization against mu ...... tokine and in vivo protection.
@en
prefLabel
Active immunization against mu ...... tokine and in vivo protection.
@en
P2093
P1433
P1476
Active immunization against mu ...... ytokine and in vivo protection
@en
P2093
Bernier EM
Bertin-Maghit SM
Boissier MC
Cavaillon JM
Haumont PM
Laborie MA
P304
P356
10.1016/J.VACCINE.2004.01.064
P407
P577
2004-08-01T00:00:00Z